Modeling Barth syndrome using patient-specific, iPSC-derived cardiomyocytes

Using Patient Specific iPSC-Cardiomyocytes for Disease ModelingПодробнее

Diabetic Cardiomyopathy Modeling & Screening with iPSC CardiomyocytesПодробнее

Human pluripotent stem cells in understanding genetic cardiovascular disease and effects of drugsПодробнее

Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, & Endothelial Cells l Protocol PreviewПодробнее

Probing disease mechanisms in ALS using iPSCs, reprogramming and optogenetic approachesПодробнее

hiPSC-Derived Cardiomyocytes for Ischemic Heart Disease Model | Protocol PreviewПодробнее

Stem Cell Models for Barth Syndrome | Dr. Hilary Vernon - Maryland Stem Cell Research FundПодробнее

Modeling the Mitochondrial Myopathy of Barth Syndrome using iPSC and Heart-on-chip TechnologiesПодробнее

Generation of induced pluripotent stem cell-derived cardiomyocytes for disease modelingПодробнее

iPSC Derived Neurons Used for Rare Disorder Modeling | Ivy Dick - Maryland Stem Cell Research FundПодробнее

Using iPSC-derived Cardiomyocytes to Study the Genetics of Left Ventricular HypertrophyПодробнее

Heart disease in Barth syndrome: Diagnosis and managementПодробнее

The mechanism of tafazzinПодробнее

PSCs to Cardiomyocytes in Three StepsПодробнее

Webinar: Using Human Cardiomyocytes in Phenotypic Screens and Target VerificationПодробнее

Regulation of Cardiomyopathy in Barth Syndrome by ALCAT1Подробнее

Megan McCain: Modeling Barth syndrome-associated cardiomyopathyПодробнее

Human iPSC-based disease modeling and therapeutic developmentПодробнее

SPS 2018: Implementing Human iPSC-derived Cells in Early Safety Assessment & Disease ModelingПодробнее